New immunotherapy for metastatic non-small cell lung cancer shows promise in clinical trial.
31-05-2020 20:03
Auteur: Reviewed by Emily Henderson, B.Sc.A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology and oncology for Atlantic Health System.Early results appear promising in this phase 1/2...